BNET Industries
- Private
Contact Information
NAICS Code Colleges, Universities, and Professional Schools: 611310
Recent Events
-
U2 to perform at U of M TCF Bank Stadium
-
$8M for turbine research
-
University of Minnesota
-
Gophers center Jeff Tow-Arnett out for season with broken leg
-
University of Minnesota releases new wheat variety
-
University of Minnesota Sues Met Council Over Central Corridor Project
-
University of Minnesota researcher to head med school operations
News & Analysis
Filter by
cell and university of minnesota - All News and Analysis
An experiment to save a son
MINNEAPOLIS -- A little boy, 18 months old, trains his solemn brown eyes on visitors to his room here at the University of Minnesota Children's Hospital, then, after a moment, breaks into a smile. He doesn't have a lot to smile about. His face is marked...
Scientists Contribute to the Development of Potential Therapeutics for Toxic Shock Syndrome
To: MEDICAL EDITORSContact: Virginia S. Bowditch of the Boston Biomedical Research Institute, +1-617-658-7711, Sullivan@bbri.org WATERTOWN, Mass., June 28 /PRNewswire-USNewswire/ -- Published in this month's issue of the journal Nature Medicine, a collaborative team of scientists from the University of Illinois, the University of Minnesota Medical School and the Boston Biomedical...
Flawed stem cell data withdrawn.
Byline: Peter Aldhous and Eugenie Samuel Reich Feb 20, 2007 (New Scientist - ABIX via COMTEX) -- Some of the data contained within the best-known stem cell papers in the past five years is being questioned. For example, in 2002, Catherine Verfaillie of the ...
Cryobanks International, Inc. Research Affiliates at the Center of Two Important Cord Blood Discoveries
Reports published earlier this month support the increased diversity of the non-controversial umbilical cord blood stem cell. Researchers based at Newcastle University in the United Kingdom have grown an artificial mini-liver from umbilical cord blood stem cells. In a separate study scientists at the Clinical Cell Therapy Lab at the...
Cytotherapy Report Confirms BioE Stem Cell First Human Cord Blood Stem Cell to Differentiate into Lung Cell
BioE and University of Minnesota Extend Stem Cell Research Agreement to Further Evaluate MLPC to Treat Lung Injuries and Respiratory Disease ST. PAUL, Minn. -- BioE([R]), Inc., a biomedical company providing human umbilical cord blood stem cells as enabling, high-quality cellular tools for drug discovery and therapeutic research, announced...
BioE Stem Cell First Human Cord Blood Stem Cell to Turn into Lung Cell; University of Minnesota Researchers Differentiate MLPC into Type II Alveolar Cells
ST. PAUL, Minn. -- Studies Continue to Evaluate Clinical and Therapeutic Potential of Rare Cord Blood Stem Cell to Treat Respiratory Conditions BioER, Inc., a biomedical company providing human cord blood stem cells as enabling, high-quality cellular tools for drug discovery and therapeutic research, announced today researchers at the...
Research Studies Confirm Promise of Novel Cord Blood Stem Cell from BioE
ST. PAUL, Minn. -- Comparative study finds MLPC offers "exciting capabilities for tissue engineering applications"; Collaborative study proves MLPC has significant differentiation capabilities BioER, Inc., a biomedical company providing non-embryonic, human stem cells, announced today that studies conducted by researchers at the University of Newcastle upon Tyne in the...
University of Minnesota obtains United States patent.(for transgenic non-human eukaryotic animal)(Brief Article)
University of Minnesota (Minneapolis, MN) and Johns Hopkins University (Baltimore, MD) has patented a transgenic non-human eukaryotic animal whose germ cells and somatic cells contain the amyloid precursor protein sequence introduced into the animal, or an ancestor of the animal, at an embryonic stage. In mice,...
Scientist supports cause on two fronts.
Aug 22, 2002 The Age ABIX via COMTEX -- A prominent US scientist says research on both adult and embryonic stem cells is necessary. The University of Minnesota's Catherine Verfaillie has made advances in researching adult stem cells, leading some Australian Government ministers to...
Protide Pharmaceuticals, Inc. Signs Option Agreement With the University of Minnesota
Business Editors & Health/Medical Writers ST. PAUL, Minn.--BUSINESS WIRE--March 13, 2001 Protide Pharmaceuticals, Inc. Protide, (OTCBB:PPMD) announced today it has signed an option agreement with the University of Minnesota Office of Patents and Technology Marketing for an infusible grade solution for non-cryopreserved human hematopoietic stem cells. The technology...
- 1



